0      0

Short Talk: Tumor CD155 Drives Resistance to Immunotherapy by Downregulating the Activating Receptor CD226 in CD8+ T Cells

Aug 17, 2020 5:55pm ‐ Aug 17, 2020 6:10pm

Credits: None available.



Credits: None available.

You must be logged in and own this session in order to post comments.